1 Min Read
Oct 19 (Reuters) - Concert Pharmaceuticals Inc:
* Concert Pharma says patent trials and appeal board of u.s. patent and trademark office has denied Incyte’s petition to institute IPR Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.